OTC · RAFA
Healthcare · Drug Manufacturers - Specialty & Generic
$0.04
Up+$0.00 (+0.00%)
Updated Aug 24, 2026, 12:11 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
RAFA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning RAFA.
RAFA research
Company profile and research snapshot.
RAFARMA PHARMA (WY)
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Jul 3, 2024
Rafarma Pharmaceuticals has signed a preliminary agreement to establish a joint venture with the Korean pharmaceutical company Woods Medical Care in Busan, South Korea. The venture will focus on the production and sale of medical products based on the isotope Yttrium-90, as well as boron and lithium capture therapy units.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RAFA.
No results
No recent SID articles mention RAFA.
